AI-assisted blue light cystoscopy for bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new AI tool that helps doctors see bladder tumors better during a blue light cystoscopy. You may be eligible if you are scheduled for this procedure and your doctor has prescribed a special dye (Hexvix or Cysview) to use during it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You sign a consent form agreeing to be in the study.
- Your doctor has prescribed a medication called Hexvix or Cysview (a dye that helps blue light show tumors) as part of your normal care.
- Your doctor plans to do a blue light cystoscopy (a procedure with a special scope) and take small tissue samples (biopsies) if needed.
- You have not taken part in this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI-powered camera system helps find bladder cancer better than a standard camera during a cystoscopy. If you are an adult with suspected new or returning bladder cancer, you may be able to join.
This trial tests if using blue light during surgery helps remove all cancer in people with high-risk non-muscle invasive bladder cancer. It may lower the chance of the cancer coming back.
This trial uses a special blue-light camera during a bladder procedure to help doctors better see non-muscle-invasive bladder cancer. It may help find cancer spots more clearly so they can be treated sooner.
This trial tests an AI-assisted camera system that looks inside the bladder to help find bladder cancer. It may help diagnose cancer more accurately during a routine procedure.
This study tests an artificial-intelligence (AI) system during real-time bladder evaluation to better spot bladder tumors. It may help your care team find tumors more accurately during diagnosis or follow-up.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.